Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer ; volume:18 ; number:1 ; day:9 ; month:11 ; year:2018 ; pages:1-8 ; date:12.2018
BMC urology ; 18, Heft 1 (9.11.2018), 1-8, 12.2018
- Urheber
-
Mansour, Ahmed M.
Abdelrahim, Mona
Laymon, Mahmoud
Elsherbeeny, Mamdouh
Sultan, Mohammed
Shokeir, Ahmed
Mosbah, Ahmed
Abol-Enein, Hassan
Awadalla, Amira
Cho, Eunho
Sairam, Vikram
Park, Taeeun D.
Shahid, Muhammad
Kim, Jayoung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-018-0413-9
- URN
-
urn:nbn:de:101:1-2018122723584537985547
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:56 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mansour, Ahmed M.
- Abdelrahim, Mona
- Laymon, Mahmoud
- Elsherbeeny, Mamdouh
- Sultan, Mohammed
- Shokeir, Ahmed
- Mosbah, Ahmed
- Abol-Enein, Hassan
- Awadalla, Amira
- Cho, Eunho
- Sairam, Vikram
- Park, Taeeun D.
- Shahid, Muhammad
- Kim, Jayoung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
2‐Aryl Imidazolium Salts as Potential Bladder Cancer Chemotherapeutic Candidates
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
2‐Aryl Imidazolium Salts as Potential Bladder Cancer Chemotherapeutic Candidates
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
2‐Aryl Imidazolium Salts as Potential Bladder Cancer Chemotherapeutic Candidates